Zofenopril attenuates injury induced by ischemia-reperfusion on rat ovary

J Obstet Gynaecol Res. 2015 Jun;41(6):926-31. doi: 10.1111/jog.12658. Epub 2014 Dec 29.

Abstract

Aim: The aim of the study was to investigate the effectiveness of zofenopril in an experimental model of ovarian torsion in rats with histologic and biochemical assessments.

Material and methods: Experimental procedures were performed on 35 female rats (Wistar albino). Rats were randomly divided into five groups as: sham (sham operated, n = 7); vehicle group 1 (torsion-detorsion, n = 7) with 2 h ischemia and 2 h reperfusion; vehicle group 2 (torsion-detorsion, n = 7) with 2 h ischemia and 5 days' reperfusion; zofenopril group 1 (torsion-detorsion, n = 7) with 2 h ischemia, 2 h reperfusion and a signal dose of oral 15 mg/kg zofenopril; and zofenopril group 2 (torsion-detorsion, n = 7) with 2 h ischemia, 5 days' reperfusion and 5 days' oral 15 mg/kg zofenopril. A scoring of histopathologic evaluation was performed on the ovaries according to congestion, bleeding, edema, and cellular degeneration. Biochemical assessments included catalase, tissue malondialdehyde and protein carbonyl.

Results: Compared with the vehicle groups, histopathologic scores, tissue malondialdehyde and protein carbonyl levels, which reflect oxidative stress markers, were significantly lower in the zofenopril groups. Furthermore, catalase levels were significantly increased in the zofenopril group.

Conclusion: Our study results revealed that zofenopril attenuates injury induced by ischemia-reperfusion on rat ovary.

Keywords: antioxidant; ischemia-reperfusion injury; ovarian torsion; zofenopril.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / therapeutic use*
  • Biomarkers / metabolism
  • Captopril / administration & dosage
  • Captopril / analogs & derivatives*
  • Captopril / therapeutic use
  • Catalase / antagonists & inhibitors
  • Catalase / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Malondialdehyde / antagonists & inhibitors
  • Malondialdehyde / metabolism
  • Ovarian Diseases / etiology
  • Ovarian Diseases / metabolism
  • Ovarian Diseases / pathology
  • Ovarian Diseases / prevention & control*
  • Ovary / blood supply
  • Ovary / drug effects*
  • Ovary / metabolism
  • Ovary / pathology
  • Oxidative Stress / drug effects*
  • Protein Carbonylation / drug effects
  • Random Allocation
  • Rats, Wistar
  • Reperfusion Injury / etiology
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / pathology
  • Reperfusion Injury / prevention & control*
  • Torsion, Mechanical

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antioxidants
  • Biomarkers
  • zofenopril
  • Malondialdehyde
  • Captopril
  • Catalase